Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.

David R BoulwareChristopher J LindsellThomas G StewartAdrian F HernandezSean CollinsMatthew William McCarthyDushyantha JayaweeraNina GentileMario CastroMark SulkowskiKathleen McTigueG Michael FelkerAdit A GindeSarah E DunsmoreStacey J AdamAllison DeLongGeorge J HannaApril RemalyFlorence ThicklinRhonda WilderSybil WilsonElizabeth ShenkmanSusanna Naggienull null

Published in: The New England journal of medicine (2023)

Treatment with inhaled fluticasone furoate for 14 days did not result in a shorter time to recovery than placebo among outpatients with Covid-19 in the United States. (Funded by the National Center for Advancing Translational Sciences and others; ACTIV-6 ClinicalTrials.gov number, NCT04885530.).

Keyphrases

coronavirus disease
sars cov
cystic fibrosis
randomized controlled trial
clinical trial
respiratory syndrome coronavirus